July 05, 2025 05:32 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Vijay named as TVK's CM face for upcoming Tamil Nadu polls | India says only Dalai Lama can decide his successor, China responds with warning | Pakistan had 30-45 seconds to respond: Shehbaz Sharif's aide on India's BrahMos attack during Op. Sindoor | Calcutta HC orders closure of all Bengal college union rooms until fresh elections in wake of Kolkata rape case | ‘We will cross that bridge when we come to it’: Jaishankar’s response on US bill proposing 500% tariffs | 'We slapped because of his attitude': MNS worker justifies assault on shopkeeper for not speaking Marathi | 'Marathi will have to be spoken in Maharashtra': State minister after MNS workers' assault on shopkeeper | PM Modi conferred with 'The Officer of the Order of the Star of Ghana' | Three Indian nationals abducted in Al-Qaeda-linked group's attack in Mali, MEA expresses 'deep concern' | Pune woman raped by man posing as delivery boy, police probe on
IPO

Mankind Pharma IPO to open on Apr 25

| @indiablooms | Apr 20, 2023, at 01:11 am

Mumbai/IBNS: Mankind Pharma Ltd will launch its initial public offering (IPO) of 40,058,844 equity shares on Tuesday, April 25, 2023, the company said on Wednesday.

The IPO will close on Thursday, April 27, 2023.

The anchor investor bidding date is on April 24, 2023, a day before the IPO date.

The price band of the offer has been fixed from Rs 1,026 per equity share to Rs 1,080 per equity share.

Bids can be made for a minimum of 13 equity shares and in multiples of 13 equity shares thereafter.

The company’s IPO is fully an offer for sale of 40,058,844 equity shares by its promoters and other shareholders.

At the upper band of the price range, the Delhi-based drug maker plans to raise around Rs 4,326.36 crore.

Those selling shares are promoters Ramesh Juneja, Rajeev Juneja and Sheetal Arora.

Further, investors Cairnhill CIPEF Ltd, Cairnhill CGPE Ltd, Beige Ltd and Link Investment Trust will also participate in the OFS.

Since the IPO is completely an OFS, any net proceeds from the issue and the entire net proceeds will go to the selling shareholders.

The equity shares offered through the red herring prospectus (RHP) are proposed to be listed on both BSE and NSE.

Kotak Mahindra Capital Company Ltd, Axis Capital Limited, IIFL Securities Limited, Jefferies India Private Limited, and J.P. Morgan India Private Limited the book-running lead managers to the issue.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.
Related Videos
RBI announces repo rate cut Jun 06, 2025, at 10:51 am
FM Nirmala Sitharaman presents Budget 2025 Feb 01, 2025, at 03:45 pm
Nirmala Sitharaman on Budget 2024 Jul 23, 2024, at 09:30 pm
Close menu